Commentary

Video

Choosing RNA Over DNA Testing for NRG1 Fusions in Pancreatic Cancer

Author(s):

E. Gabriela Chiorean, MD, SCCA

E. Gabriela Chiorean, MD, of Fred Hutch Cancer Center, discusses the benefits and challenges of DNA and RNA testing for NRG1 fusions in patients with pancreatic cancer.

Related Videos
Suneel Kamath, MD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the multidisciplinary management of NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of pathologists in molecular testing in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of RNA and other testing considerations for detecting NRG1 and other fusions in solid tumors.
Mary B. Beasley, MD, discusses the prevalence of NRG1 fusions in non–small cell lung cancer and pancreatic cancer.
Shubham Pant, MD, MBBS
Brett L. Ecker, MD
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Related Content
NRG1 Fusions in Lung Cancer | Image Credit: © catalin – stock.adobe.com
December 17th 2024

NRG1 Fusions Emerge as New Target of Interest in Lung, Pancreatic Cancers

FDA
December 4th 2024

FDA Grants Accelerated Approval to Zenocutuzumab for NRG1+ NSCLC and Pancreatic Adenocarcinoma

Pancreatic Cancer - stock.adobe.com
December 2nd 2024

Tumor Treating Fields Plus Chemotherapy Improves OS in Unresectable Pancreatic Cancer

Pancreatic cancer / Image credit: magicmine — stock.adobe.com
December 2nd 2024

CM24 Plus Nivolumab and Chemo Displays Efficacy vs Chemo Alone in Metastatic PDAC

Suneel Kamath, MD
November 30th 2024

Targeted Therapies Remain Central to Ongoing Research in Pancreatic Cancer

Suneel Kamath, MD, of Cleveland Clinic
November 27th 2024

Pancreatic Cancer Awareness Month Brings Attention to Growing Incidence and Treatment Advances